X-group (possible homology)

7087 Emopamil binding protein (EBP) transmembrane domain

Ligands and drugs

127
Member domains
28
with ligand contacts (≤ 4 Å)
22.0% of members
24
with DrugDomain annotations
18.9% of members
14
with a DrugBank compound
11.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

2
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Phenylpropanoids and polyketides10.024×not tested
Lipids and lipid-like molecules20.29.11×not tested
Benzenoids10.16.94×not tested
Organic oxygen compounds10.42.55×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB04540CLRCholesterol5
DB13080YT7Roluperidone4
DB00675CTXTamoxifen3

Most frequently bound compounds

PDB ligandNameDomains in contact
OLC(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate18
CLRCHOLESTEROL5
YT1PB284
YT7Roluperidone4
YTD6-({[(1S)-1-hydroxy-2-methyl-1-phenylpropan-2-yl]amino}methyl)-1-methyl-3,4-dihydroquinolin-2(1H)-one4
CTX(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE3
MKM3beta-(2-Diethylaminoethoxy)androst-5-en-17-one3
A1AEU1-methyl-1'-[(oxan-4-yl)methyl]-5-(trifluoromethyl)spiro[indole-2,4'-piperidin]-3(1H)-one2
A1AEV1-methyl-8-[(oxan-4-yl)methyl]-3-[4-(trifluoromethyl)phenyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione2
ZNC3-[1-(3-phenylpropyl)-1,2,3,6-tetrahydropyridin-4-yl]-1H-pyrrolo[2,3-b]pyridine2